The Global Vascular Access Devices Market was valued at USD 5.8 billion in 2024 and is estimated to grow at a CAGR of 7.1% to reach USD 11.5 billion by 2034. Demand for these devices is being propelled by the rising burden of chronic health conditions that require long-term or repeated intravenous therapies. Across the healthcare spectrum, patients undergoing treatment for serious ailments often require sustained drug delivery, nutritional support, or fluid management, which calls for dependable vascular access solutions.
In clinical settings, vascular access devices are essential for delivering medications, drawing blood, administering fluids, and performing other critical procedures. Their role becomes even more vital with the growing number of patients needing intensive care, surgical procedures, and specialized treatments. As healthcare systems expand in developing countries and upgrade technologies in established markets, the need for vascular access equipment continues to grow in both acute and non-acute care environments.
These devices are specifically designed to provide direct and efficient access to the bloodstream for a range of treatments. They are widely used in both short-term scenarios, such as surgical procedures, and for long-duration therapies like dialysis or chemotherapy. As the healthcare landscape shifts toward more outpatient and home-based care models, the use of these devices outside hospital settings is also gaining traction. Innovations in device materials and design have contributed to greater safety, minimizing complications like infections and blood clots, and improving ease of use for medical personnel. Vascular access equipment has thus become integral to modern healthcare delivery, ensuring both patient safety and procedural efficiency.
The market is categorized into peripheral and central vascular access devices. In 2024, central vascular access devices held the dominant position, generating 63.9% of the total market revenue. These devices are frequently preferred in situations requiring consistent or repeated intravenous treatments, especially in complex therapeutic regimens. Their ability to remain in place for extended durations and deliver drugs directly into large veins makes them particularly suitable for long-term applications. Among the various central access options, devices such as peripherally inserted central catheters, tunneled catheters, and implantable ports are widely used due to their lower insertion frequency and enhanced patient comfort.
Recent advancements in this segment have led to the development of vascular devices with improved antimicrobial properties and anti-clotting features. These product upgrades are designed to minimize risks associated with prolonged usage, such as catheter-related bloodstream infections, and enhance device reliability. Additionally, the integration of imaging technologies in insertion techniques has made placements more accurate and safer, contributing to the overall efficiency of treatment protocols.
From an application standpoint, drug administration accounted for the highest revenue, reaching USD 2.4 billion in 2024. This segment continues to thrive due to the growing need for continuous infusion therapies in patients with chronic illnesses. Medications, including antibiotics, biologics, and immunotherapies, often require prolonged intravenous access, which makes vascular access devices indispensable. As medical practices increasingly support home infusion services and outpatient therapy to reduce hospitalization costs, vascular access tools are becoming more common in homecare environments as well.
The market is also segmented by end users, including hospitals and clinics, ambulatory surgical centers, homecare settings, and others. Hospitals and clinics emerged as the leading segment, with a market share of 56.2% in 2024. The consistent rise in surgical volumes, along with a higher patient inflow for both acute and chronic care, sustains a strong demand for vascular devices in these facilities. These settings frequently utilize both peripheral IVs for routine procedures and central lines for more complex treatment needs. Infection prevention and compliance with regulatory standards are critical concerns, prompting hospitals to invest in advanced access devices that incorporate closed-system designs and antimicrobial materials.
Regionally, North America led the market, generating USD 2.6 billion in revenue in 2024 and is forecasted to grow at a CAGR of 7% over the next decade. Within this region, the United States is expected to see its vascular access device market grow from USD 2.3 billion in 2024 to USD 4.6 billion by 2034. The increasing prevalence of long-term health conditions, combined with a shift toward outpatient care and at-home treatment programs, supports continued market expansion. The demand for effective, durable, and safer vascular access options remains high, driven by healthcare providers striving for quality outcomes and patient-centered solutions.
The competitive landscape of the market includes prominent industry players that focus on innovation and product performance. Companies such as Becton Dickinson and Company, Teleflex, B. Braun, Medtronic, and Fresenius Medical Care collectively captured approximately 60% of the global market share in 2024. Market dynamics are heavily influenced by advancements in product technology and cost considerations, particularly in price-sensitive regions. Multinational corporations often face pressure to balance affordability with quality, while local manufacturers position themselves as providers of cost-effective yet compliant alternatives. This balance between innovation and accessibility will remain a defining feature of the vascular access devices market in the years ahead.
This product will be delivered within 2-4 business days.
In clinical settings, vascular access devices are essential for delivering medications, drawing blood, administering fluids, and performing other critical procedures. Their role becomes even more vital with the growing number of patients needing intensive care, surgical procedures, and specialized treatments. As healthcare systems expand in developing countries and upgrade technologies in established markets, the need for vascular access equipment continues to grow in both acute and non-acute care environments.
These devices are specifically designed to provide direct and efficient access to the bloodstream for a range of treatments. They are widely used in both short-term scenarios, such as surgical procedures, and for long-duration therapies like dialysis or chemotherapy. As the healthcare landscape shifts toward more outpatient and home-based care models, the use of these devices outside hospital settings is also gaining traction. Innovations in device materials and design have contributed to greater safety, minimizing complications like infections and blood clots, and improving ease of use for medical personnel. Vascular access equipment has thus become integral to modern healthcare delivery, ensuring both patient safety and procedural efficiency.
The market is categorized into peripheral and central vascular access devices. In 2024, central vascular access devices held the dominant position, generating 63.9% of the total market revenue. These devices are frequently preferred in situations requiring consistent or repeated intravenous treatments, especially in complex therapeutic regimens. Their ability to remain in place for extended durations and deliver drugs directly into large veins makes them particularly suitable for long-term applications. Among the various central access options, devices such as peripherally inserted central catheters, tunneled catheters, and implantable ports are widely used due to their lower insertion frequency and enhanced patient comfort.
Recent advancements in this segment have led to the development of vascular devices with improved antimicrobial properties and anti-clotting features. These product upgrades are designed to minimize risks associated with prolonged usage, such as catheter-related bloodstream infections, and enhance device reliability. Additionally, the integration of imaging technologies in insertion techniques has made placements more accurate and safer, contributing to the overall efficiency of treatment protocols.
From an application standpoint, drug administration accounted for the highest revenue, reaching USD 2.4 billion in 2024. This segment continues to thrive due to the growing need for continuous infusion therapies in patients with chronic illnesses. Medications, including antibiotics, biologics, and immunotherapies, often require prolonged intravenous access, which makes vascular access devices indispensable. As medical practices increasingly support home infusion services and outpatient therapy to reduce hospitalization costs, vascular access tools are becoming more common in homecare environments as well.
The market is also segmented by end users, including hospitals and clinics, ambulatory surgical centers, homecare settings, and others. Hospitals and clinics emerged as the leading segment, with a market share of 56.2% in 2024. The consistent rise in surgical volumes, along with a higher patient inflow for both acute and chronic care, sustains a strong demand for vascular devices in these facilities. These settings frequently utilize both peripheral IVs for routine procedures and central lines for more complex treatment needs. Infection prevention and compliance with regulatory standards are critical concerns, prompting hospitals to invest in advanced access devices that incorporate closed-system designs and antimicrobial materials.
Regionally, North America led the market, generating USD 2.6 billion in revenue in 2024 and is forecasted to grow at a CAGR of 7% over the next decade. Within this region, the United States is expected to see its vascular access device market grow from USD 2.3 billion in 2024 to USD 4.6 billion by 2034. The increasing prevalence of long-term health conditions, combined with a shift toward outpatient care and at-home treatment programs, supports continued market expansion. The demand for effective, durable, and safer vascular access options remains high, driven by healthcare providers striving for quality outcomes and patient-centered solutions.
The competitive landscape of the market includes prominent industry players that focus on innovation and product performance. Companies such as Becton Dickinson and Company, Teleflex, B. Braun, Medtronic, and Fresenius Medical Care collectively captured approximately 60% of the global market share in 2024. Market dynamics are heavily influenced by advancements in product technology and cost considerations, particularly in price-sensitive regions. Multinational corporations often face pressure to balance affordability with quality, while local manufacturers position themselves as providers of cost-effective yet compliant alternatives. This balance between innovation and accessibility will remain a defining feature of the vascular access devices market in the years ahead.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
Chapter 9 Company Profiles
COMPANIES MENTIONED
The companies featured in this vascular access devices market report include:- Access Vascular
- AngioDynamics
- B Braun
- Becton Dickinson and Company
- ConvaTec
- Cook Medical
- Fresenius Medical Care
- ICU Medical
- Medical Components
- Medtronic
- Nipro
- Penumbra
- Teleflex
- Terumo
- Vygon
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | June 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 5.8 Billion |
| Forecasted Market Value ( USD | $ 11.5 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
